Ledger.Open graph →
SEC Form D · filed December 6, 2022

Lusaris Therapeutics, Inc

Offering
$60.2M
Sold
$60.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Morrisville, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Andrew Levin · BOSTON, MAExec · DirectorCatherine Riesen · Morrisville, NCExecDaniel Grau · Boston, MADirectorNeil Buckley · Morrisville, NCExecNeil Buckley · Morrisville, NCExecRamin Farzaneh-Far · Morrisville, NCExecRamin Farzaneh-Far · Morrisville, NCExecCatherine Riesen · Morrisville, NCExecEdward Monaghan · Morrisville, NCExec · Director · PromoterAndrew Levin · Boston, MAExec · DirectorEdward Monaghan · Morrisville, NCExec · Director · PromoterDaniel Grau · Morrisville, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗